Listed

Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
FiledFormWhat it isAccession number
2016-08-0518:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-011536
2016-08-0417:21 ET10-QQuarterly reportPeriod 2016-06-300001628280-16-018534
2016-07-1917:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-011142
2016-07-1817:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-011128
2016-07-1418:22 ETSC 13DOwnership report, active investor0001193125-16-647461
2016-07-1317:23 ETSC 13DOwnership report, active investor0000903423-16-001151
2016-07-1317:16 ETSC 13DOwnership report, active investor0001144204-16-112848
2016-07-1316:46 ETSC 13DOwnership report, active investor0001104659-16-132418
2016-06-3008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-010904
2016-06-0812:19 ET8-K1.01 Entry into a material agreement0000912282-16-000747
2016-06-0308:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-010457
2016-06-0108:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-010408
2016-05-2514:08 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000912282-16-000733
2016-05-0416:07 ET10-QQuarterly reportPeriod 2016-03-310001628280-16-015493
2016-05-0416:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-009680
2016-05-0316:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-009641
2016-04-2908:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-009506
2016-04-2713:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-009422
2016-04-2514:20 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000912282-16-000695
2016-04-2208:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-009327
2016-04-1408:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-009153
2016-04-0818:51 ETDEF 14AProxy statementPeriod 2016-05-190001628280-16-014088
2016-03-3014:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-008914
2016-03-1119:44 ET10-K/AAnnual report, amendedPeriod 2015-12-310001628280-16-012607
2016-03-0913:47 ET10-KAnnual reportPeriod 2015-12-310001628280-16-012462
2016-03-0908:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-008459
2016-03-0808:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-008433
2016-03-0317:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-008346
2016-02-1714:09 ETSC 13D/AOwnership report, active investor, amended0001104659-16-097653
2016-02-1717:34 ETSC 13D/AOwnership report, active investor, amended0001193125-16-465765
2016-02-0416:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-007660
2016-01-1106:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-007123
2015-11-0517:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-006068
2015-11-0516:37 ET10-QQuarterly reportPeriod 2015-09-300001062993-15-005809
2015-10-2808:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-005748
2015-10-1508:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-005543
2015-10-0713:00 ET8-K1.02 Termination of a material agreement0001171843-15-005432
2015-10-0608:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-005414
2015-10-0110:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-005376
2015-09-0917:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-005097
2015-08-2508:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-004875
2015-08-0716:39 ET10-QQuarterly reportPeriod 2015-06-300001171843-15-004476
2015-08-0708:50 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-004467
2015-08-0516:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-004369
2015-08-0308:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-004256
2015-08-0306:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-004252
2015-07-2008:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003907
2015-07-1617:26 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors0000912282-15-000243
2015-07-1516:05 ET10-Q/AQuarterly report, amendedPeriod 2015-03-310001171843-15-003849
2015-07-1411:30 ET8-K5.07 Shareholder vote results0001171843-15-003813

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.